RxDoctor Payments Data

Michael Latzka, MD

Family Medicine · Spartanburg, SCNPI 1538127543

Payments from drug & device makers

$7,777in general payments, 2019–2025

Across 480 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$873
  • AbbVie$740
  • Pfizer$538
  • GSK$478
  • Novo Nordisk$415
  • Amgen$349
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$7,777100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)42$873
AbbVie(2 entities)55$740
Pfizer35$538
GSK35$478
Novo Nordisk30$415
Amgen22$349
Abbott17$346
Boehringer Ingelheim19$266
Lilly USA, LLC16$213
Daiichi Sankyo Inc.11$210
Mannkind Corporation12$192
Sanofi-aventis U.S. LLC11$182
Amarin Pharma, Inc.12$178
Bayer10$173
Dexcom, Inc.10$170
Esperion Therapeutics, Inc.9$166
Biohaven Pharmaceuticals, Inc.7$152
Kowa Pharmaceuticals America, Inc.11$145
Takeda Pharmaceuticals U.S.A., Inc.10$137
Novartis8$137
Medtronic4$127
Antares Pharma, Inc.8$116
Merck7$113
Astellas Pharma US Inc6$107
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$78
Exact Sciences5$74
Eisai Inc.4$71
Biohaven Pharmaceutical Holding Company Ltd.4$70
Genentech USA, Inc.4$62
Insulet Corporation2$54
Sumitomo Pharma America, Inc.2$50
Phathom Pharmaceuticals, Inc.3$50
Seqirus USA Inc3$45
Xeris Pharmaceuticals, Inc.2$35
Inari Medical, Inc.2$34
Shield Therapeutics Inc2$33
Mylan Specialty L.p.2$32
Johnson & Johnson2$31
Zealand Pharma US, Inc.1$29
Arbor Pharmaceuticals, Inc.1$29
Currax Pharmaceuticals LLC2$28
Recor Medical Inc1$26
VBI Vaccine (delaware) Inc.1$25
Ironwood Pharmaceuticals, Inc2$24
Stryker1$22
Supernus Pharmaceuticals, Inc.1$22
Abiomed1$22
Clarus Therapeutics Inc.2$21
Nabriva Therapeutics, PLC1$19
Axsome Therapeutics, Inc.1$19
Halozyme Inc1$19
Verona Pharma, Inc.1$18
Edwards Lifesciences1$18
Cranial Technologies, Inc1$16
E.r. Squibb & Sons, L.L.C.1$16
Philips North America LLC1$16
Vivus LLC1$15
Inspire Medical Systems, Inc.1$15
Sanofi Pasteur Inc.1$15
Corcept Therapeutics1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,777 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$415,142
Medicare patients
563
Services billed
11,389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban198$150,877
FarxigaDapagliflozin Propanediol138$113,567
XareltoRivaroxaban93$71,995
OzempicSemaglutide54$57,340
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog88$55,717
JanuviaSitagliptin Phosphate72$51,108
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$46,256
JardianceEmpagliflozin35$37,953
JanumetSitagliptin Phos/Metformin Hcl37$33,044
Breo ElliptaFluticasone/Vilanterol55$25,274
LinzessLinaclotide37$20,281
TrulicityDulaglutide15$19,107
InvokanaCanagliflozin12$16,081
MounjaroTirzepatide13$14,348
Tresiba Flextouch U-200Insulin Degludec21$14,324

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$538$150,877198 claims
AstraZenecaFarxiga, Brilinta, Breztri Aerosphere$873$135,230171 claims
MerckJanuvia, Janumet, Janumet Xr$113$98,054120 claims
Johnson & JohnsonXarelto, Invokana$31$88,076105 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$478$80,765131 claims
Novo NordiskOzempic$415$57,34054 claims
Boehringer IngelheimJardiance, Stiolto Respimat$266$46,31547 claims
Lilly USA, LLCTrulicity, Mounjaro$213$33,45528 claims
AbbVieLinzess$740$20,28137 claims
Astellas Pharma US IncMyrbetriq$107$8,80718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →